advertisement
Yan Y 10
Showing records 1 to 10 | Display all abstracts from Yan Y109818 Evaluation of microvascular changes in the retina and choriocapillaris in primary glaucoma and neuromyelitis optica spectrum disorder with optical coherence tomography angiography
Li Y
Photodiagnosis and photodynamic therapy 2023; 43: 103699
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
109818 Evaluation of microvascular changes in the retina and choriocapillaris in primary glaucoma and neuromyelitis optica spectrum disorder with optical coherence tomography angiography
Liu W
Photodiagnosis and photodynamic therapy 2023; 43: 103699
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Peng B
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
109818 Evaluation of microvascular changes in the retina and choriocapillaris in primary glaucoma and neuromyelitis optica spectrum disorder with optical coherence tomography angiography
Yan Y
Photodiagnosis and photodynamic therapy 2023; 43: 103699
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
109818 Evaluation of microvascular changes in the retina and choriocapillaris in primary glaucoma and neuromyelitis optica spectrum disorder with optical coherence tomography angiography
Wang C
Photodiagnosis and photodynamic therapy 2023; 43: 103699
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Diao C; Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
109818 Evaluation of microvascular changes in the retina and choriocapillaris in primary glaucoma and neuromyelitis optica spectrum disorder with optical coherence tomography angiography
Guo H
Photodiagnosis and photodynamic therapy 2023; 43: 103699
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Hong Y; Lin J; Lin Y; Jiang L; Tang N; Tang F; Liang J; Zhang J; Yan Y; Chen Q; Zhou Z; Shen C; Huang W; Huang K; Lan Q; Cui L; Zhong H; Xu F; Li M; Wei Y; Lu P; Zhang M
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
